R&D Systems™ Human EG-VEGF/PK1 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Manufacturer: R&D Systems™ 1209EV025/CF
DescriptionThe Recombinant Human EG-VEGF/PK1 Protein is derived from NS0. The Recombinant Human EG-VEGF/PK1 Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|97%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Mouse myeloma cell line,NS0-derived human EG-VEGF/PK1 protein Ala20-Phe105,with a C-terminal 6-His tag|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|